Metraipolis › archive › dc_aa428de407c2

Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective — Europe PMC PMID:42942813

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42942813
DOI
10.3390/pharmaceutics18101281
License (as archived)
solo-consultazione
Archived
2026-11-01T00:19:45.499Z
SHA-256 of the archived text
3367c7ac457a4aa457ab0a543424548929d33c5a1261f3b522b512212ee287eb
Stable URL of this page
https://metraipolis.com/documento/dc_aa428de407c2

How to cite

Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective — Europe PMC PMID:42942813 — Europe PMC (en), https://europepmc.org/article/MED/42942813 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa428de407c2 (Metraipolis archive dc_aa428de407c2, sha256 3367c7ac457a4aa457ab0a543424548929d33c5a1261f3b522b512212ee287eb)
BibTeX
@misc{dcaa428de407c2,
  title = {Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective — Europe PMC PMID:42942813},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42942813},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa428de407c2; sha256 3367c7ac457a4aa457ab0a543424548929d33c5a1261f3b522b512212ee287eb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42942813. Agents can read the archived copy with the MCP tool read_document.